Senior execs from Coloplast and Novo to join Ambu board
ALK CEO Jens Bager will continue as chairman of Ambu after the General Assembly on December 10, and Mikael Worning - chief executive of William Demant’s US business - will continue as vice chairman. But beyond this, the summons to the Ambu General Assembly indicates that there are big changes in store.
Namely because Jesper Funding Anderse, senior vice president at Widex, and John Stær, will not be up for re-election.
Instead, two experienced men from the life-science sector have been nominated for the board of directors. These are Henrik Wulff, head of Novo Nordisk’s global production and part of the group executive management at the Danish diabetes group, and Oliver Johansen, also a member of senior group management, but at Coloplast. He heads the company’s global R&D department.
Ambu CEO: We are confident that we'll reach our strategic goals
Relaterede artikler
Coloplast and Ambu team up
For abonnenter
Ambu CEO: our formula fits well with the hospital market
For abonnenter
